Login     Register  
    Home   |   Search   |   Director's Bio   |   About/Contact Us   |   Disclaimer  
BioEndeavor - Empowering Women  
 Home
 About BioEndeavor
 Engaged Thinking
 Engaged Thinking Blog
 Engaged Innovation Case Studies
 Engaged Thinking Academy
 Resources
 Engaged Innovation Directory
 Capacity Development
Neglected Tropical Diseases 
Non-Communicable Diseases 

Drug Discovery 
Preclinical 
Clinical 
Healthcare 
 Add Organization 


Drug Discovery
GlaxoSmithKline Proprietary Knowledge PoolGo Back  
Organization URL

Organization:
GlaxoSmithKline Proprietary Knowledge Pool

Year Established: 2009

Profile:
Being more flexible with intellectual property could stimulate research and help to speed up development of medicines for neglected tropical diseases (NTDs). In 2009 GSK helped to establish an independent knowledge pool where GSK and others could make available patents and knowledge that may stimulate research into treatments for 16 neglected tropical diseases (NTDs). This is now known as the Pool for Open Innovation against Neglected Tropical Diseases (POINT). Since January 2010 it has been independently administered by BIO Ventures for Global Health (BVGH), a non-profit organization that aims to accelerate the development of drugs, vaccines and diagnostics to meet global needs.
Under the terms of POINT any medicines or treatments for NTDs developed using the pooled patents and intellectual property will be available to Least Developed Countries on a royalty-free basis.


Target Sector:
Drug Discovery

Typology of Knowledge Network:
Open Source Community

Knowledge Type / Focus:
Data
Biological Tools
Biological Materials

Participant Type:
Private Sector

Objective / Knowledge Governance:
Open Access
Cooperative Research

IP Management:
This is now known as the Pool for Open Innovation against Neglected Tropical Diseases (POINT). Since January 2010 it has been independently administered by BIO Ventures for Global Health (BVGH), a non-profit organization that aims to accelerate the development of drugs, vaccines and diagnostics to meet global needs. Under the terms of POINT any medicines or treatments for NTDs developed using the pooled patents and intellectual property will be available to Least Developed Countries on a royalty-free basis.


2010-2017 BioEndeavor.Net
Privacy and Security Statement Disclaimer Adding Directory Profiles